Margaret L Davis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13605 Baden Westwood Road, Brandywine, MD 20613 Phone: 301-888-2233 Fax: 301-888-9133 |
Keon M Vasudevan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7450 Albert Rd, 1st Floor, Brandywine, MD 20613 Phone: 301-888-2233 |
Dr. Rosemarie Walden Henry, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13605 Baden Westwood Road, Brandywine, MD 20613 Phone: 301-888-2233 Fax: 301-888-9133 |
Saida Morenike Sanusi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7450 Albert Rd, 1st, Brandywine, MD 20613 Phone: 301-888-2233 |
Ana R Ibanez, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13605 Baden Westwood Road, Brandywine, MD 20613 Phone: 301-888-2233 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
When biologist Barbara Boyan discovered science's first proof of biochemical differences between male and female cartilage cells, she began to question the approaches she and other researchers were taking to study cells. Was their thinking biologically relevant?
USA Today on Monday examined the use of online second-opinion services, which allow patients to receive consultations from specialists based on medical records that they fax, mail or send through the Internet
Two research units under Singapore's Agency for Science, Technology and Research (A*STAR), the Experimental Therapeutics Centre (ETC) and Singapore Immunology Network (SIgN), are collaborating with Italy's Siena Biotech S.p.A. to develop new drugs and targeted antibodies respectively, which will potentially help millions of cancer and bone loss patients across the world. This is the fifth major collaboration A*STAR has with research centres and universities in Italy .
› Verified 9 days ago